PDR® DRUG ALERTS AND REMS PROGRAMS

PDR® Network, the industry standard for drug safety communications to prescribers, offers an electronic service delivering specialty-specific FDA-approved Drug Alerts, Dear Health Care Professional Letters (DHCPLs), Risk Evaluation and Mitigation Strategy (REMS) programs, and recalls electronically to help fulfill the clinical, regulatory and compliance needs of manufacturers. Electronic delivery eliminates the delay and inefficiency of traditional paper Alert delivery, improving patient safety which may help to reduce medical liability.

The #1 means of delivering Drug Alerts and REMS to prescribers: 13.5 Million Alerts and REMS communications delivered

• Unmatched electronic reach to 425,000 opt-in prescribers
• Broad reach or specialty-specific targeting
• PDR® Drug Alerts and REMS communications delivered electronically
• CME opportunities for all PDR Drug Alerts and REMS communications

In a recent REMS product survey (PDR®, March 2011) nearly 50% of physicians indicated that they prefer to receive information from a trusted third party such as PDR. Leverage the reach and expertise of PDR Network to design and deliver impactful and cost-effective REMS Communications and Drug Alerts.

PDR® Drug Approval Notifications deliver compelling product information to your target audience. This electronic communication delivers information related to new product and new efficacy supplemental approval to include new drug or biologic approval, new indications, new patient populations, or new dosing guidelines.

Leverage the well established PDR channel to educate physicians on your new/updated labeling information.